ABL Europe
ABL Europe is a France-based bioproduction and gene therapy contract services company founded in 2016, providing manufacturing and quality control support to life sciences and public health-oriented clients.
- Company typePrivate
- Founded2016
- HeadquartersJaures, France
- Headcount101–250
- GTM typeB2B
- OfferingServices
ABL Europe firmographics
Firmographics- Name
- ABL Europe
- Website
- https://abl-biomanufacturing.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- ABL Europe is a France-based bioproduction and gene therapy contract services company founded in 2016, providing manufacturing and quality control support to life sciences and public health-oriented clients.
- Ownership category
- akta.pro rank
ABL Europe industry classification
Industry- Product category
- Biopharmaceutical CDMO Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK)
- akta.pro secondary industry
- Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)
Keywords
Where ABL Europe is headquartered
LocationHeadquarters
- HQ city
- Jaures
- HQ country
- France
- HQ region
- Europe
Markets served
ABL Europe business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain
ABL Europe product offering
Product offeringCore offering
ABL Europe specializes in bioproduction, quality control services, and gene therapy. The company assists its clients with long-term public health outcomes by delivering contract manufacturing and QC support for biologics and advanced therapy medicinal products. Operations are based in France and the firm employs 101-250 staff.
Differentiator
Problem solved
Functional benefit
Products and services
- Bioproduction Services
Companies that use ABL Europe
Customer profileIdeal customer profiles1 record
ABL Europe technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
ABL Europe competitors and assessment
Company assessmentDirect peers
- Vibalogics: Vibalogics is a German-based CDMO focused on viral vector manufacturing for gene therapy and viral vaccines. It is closely comparable to ABL Europe in both technology focus and European geographic positioning.
- Yposkesi: Yposkesi is a French-based CDMO specializing in GMP manufacturing of viral vectors for gene therapy, located near Paris. It competes directly with ABL Europe for European gene therapy manufacturing contracts.
- Cobra Biologics: Cobra Biologics (part of Charles River Laboratories) provides viral vector and plasmid DNA manufacturing for gene therapy and vaccine developers. It is a direct competitor in specialized gene therapy CDMO services.
- Aldevron: Aldevron is a US-based CDMO specializing in plasmid DNA, mRNA, and viral vector manufacturing for gene and cell therapy. It is one of the most direct competitors to ABL Europe in the specialized biologics and gene therapy CDMO space, serving the same sponsor profile.
- Biovian: Biovian is a Finnish-based CDMO offering GMP manufacturing of viral vectors, plasmids, and recombinant proteins for gene therapy and vaccines. It is a directly comparable European specialized CDMO peer.
Broad incumbents
- Lonza: Lonza is one of the world's largest CDMOs, with significant cell and gene therapy manufacturing capacity. While broader than ABL Europe, it competes directly in viral vector manufacturing and represents the largest competitive threat.
- Catalent: Catalent is a major global CDMO with a substantial gene therapy and viral vector manufacturing footprint. It is a broad incumbent competing with ABL Europe for advanced therapy manufacturing contracts.
- Thermo Fisher Scientific (Patheon): Thermo Fisher's pharma services division offers viral vector and biologics manufacturing capabilities through its Patheon and Brammer Bio operations. It is a broad incumbent with overlapping gene therapy CDMO services.
- Charles River Laboratories: Charles River Laboratories is a global CRO/CDMO with gene therapy manufacturing capabilities through its Cobra Biologics acquisition. It competes broadly with ABL Europe in biologics and gene therapy CDMO services.
Emerging players
- ABL Inc: ABL Inc, the original US-based bioproduction and gene therapy CDMO from which ABL Europe was established, provides closely related capabilities and serves as both historical parent and functional peer in the gene therapy CDMO space.
Market position
Customer concentration
ABL Europe social profiles
Digital presenceABL Europe financial estimates
Financial estimateRevenue estimate
Valuation estimate
ABL Europe leadership team
Management profileNumber of profiles
ABL Europe funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ABL Europe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ABL Europe
What does ABL Europe do?
ABL Europe specializes in bioproduction, quality control services, and gene therapy. The company assists its clients with long-term public health outcomes by delivering contract manufacturing and QC support for biologics and advanced therapy medicinal products. Operations are based in France and the firm employs 101-250 staff.
Is ABL Europe a public or private company?
ABL Europe is a private company. It is classified as unknown and is currently operating.
When was ABL Europe founded?
ABL Europe was founded in 2016. It employs 101 to 250 people.
Where is ABL Europe based?
ABL Europe is headquartered in Jaures, France, in the Europe region.
Who are ABL Europe's main competitors?
Direct peers on record are Vibalogics, Yposkesi, Cobra Biologics, Aldevron and Biovian. Broad incumbents are Lonza, Catalent, Thermo Fisher Scientific (Patheon) and Charles River Laboratories. ABL Inc is listed as an emerging player.
Does ABL Europe have an API?
No public API is recorded for ABL Europe.
What industry is ABL Europe in?
ABL Europe's product category is Biopharmaceutical CDMO Services. Its primary akta.pro industry code is HLAGACAK, Clinical Trial Pharmacy & IMP Management at Site, with a secondary code of HLAIALAH, Regulatory Strategy & IND/NDA/BLA Submissions Support. Its NAICS code is 541714 and its SIC code is 2834.